Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Centers for Disease Control and Prevention (CDC) Grants for Public Health Research Dissertation, Program Announcement (PA) PAR07-231, Panel C, 54667 [E7-18947]

Download as PDF Federal Register / Vol. 72, No. 186 / Wednesday, September 26, 2007 / Notices Ethics, Suite 500, 1201 New York Avenue, NW., Washington, DC 20005– 3917; Telephone: 202–482–9300; TDD: 202–208–9293; FAX: 202–482–9237. 5 U.S.C. 4314(c) requires each agency to establish, in accordance with regulations prescribed by the Office of Personnel Management at 5 CFR part 430, subpart C and § 430.310 thereof in particular, one or more Senior Executive Service performance review boards. As a small executive branch agency, OGE has just one board. In order to ensure an adequate level of staffing and to avoid a constant series of recusals, the designated members of OGE’s SES Performance Review Board are being drawn, as in the past, in large measure from the ranks of other agencies. The board shall review and evaluate the initial appraisal of each OGE senior executive’s performance by his or her supervisor, along with any recommendations in each instance to the appointing authority relative to the performance of the senior executive. This revised notice updates the membership of OGE’s SES Performance Review Board as it was most recently published at 72 FR 53773–53774 (September 20, 2007), in order to reflect the appointment of one new member from another agency to replace a member from an agency who was not able to serve on OGE’s board this year. SUPPLEMENTARY INFORMATION: Approved: September 21, 2007. Robert I. Cusick, Director, Office of Government Ethics. mstockstill on PROD1PC66 with NOTICES The following officials have been appointed as regular members of the SES Performance Review Board of the Office of Government Ethics: Marilyn L. Glynn [Chair], General Counsel, Office of Government Ethics Daniel D. Dunning [Alternate Chair], Deputy Director for Administration and Information Management, Office of Government Ethics Daniel L. Koffsky, Special Counsel, Office of Legal Counsel, Department of Justice David Maggi, Chief, Ethics Law and Programs Division, Office of the Assistant General Counsel for Administration, Department of Commerce; and Robert A. Shapiro, Associate Solicitor for Legal Counsel, Department of Labor DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Centers for Disease Control and Prevention (CDC) Grants for Public Health Research Dissertation, Program Announcement (PA) PAR07–231, Panel B Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Centers for Disease Control and Prevention (CDC) Grants for Public Health Research Dissertation, Program Announcement (PA) PAR07–231, Panel C In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 8 a.m.–4 p.m., November 15, 2007 (Closed). Place: Crowne Plaza Buckhead, 3377 Peachtree Road, NE., Atlanta, GA 30326, telephone 404–264–1111. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘CDC Grants for Public Health Research Dissertation,’’ PA PAR07–231, Panel B. Contact Person for More Information: Susan B. Stanton, D.D.S., Scientific Review Administrator, Office of the Chief Science Officer, CDC, 1600 Clifton Road, NE., Mailstop D 72, Atlanta, GA 30333, Telephone 404–639–4640. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: September 20, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–18945 Filed 9–25–07; 8:45 am] Jkt 211001 Time and Date: 8:30 a.m.–4 p.m., November 16, 2007 (Closed). Place: Crowne Plaza Buckhead, 3377 Peachtree Road, NE., Atlanta, GA 30326, telephone 404–264–1111. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘CDC Grants for Public Health Research Dissertation,’’ PAR07–231, Panel C. Contact Person for More Information: Sheree Marshall Williams, Ph.D., M.Sc., Scientific Review Administrator, Office of the Chief Science Officer, CDC, 1600 Clifton Road, NE., Mailstop D 72, Atlanta, GA 30333, Telephone 404–639–4896. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: September 20, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–18947 Filed 9–25–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the President’s Cancer Panel. The meeting will be open to the public as indicated below, with attendance limited to space available. BILLING CODE 6345–02–P 17:57 Sep 25, 2007 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. BILLING CODE 4163–18–P [FR Doc. E7–18973 Filed 9–25–07; 8:45 am] VerDate Aug<31>2005 54667 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 E:\FR\FM\26SEN1.SGM 26SEN1

Agencies

[Federal Register Volume 72, Number 186 (Wednesday, September 26, 2007)]
[Notices]
[Page 54667]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-18947]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Centers for Disease Control and Prevention (CDC) 
Grants for Public Health Research Dissertation, Program Announcement 
(PA) PAR07-231, Panel C

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time and Date: 8:30 a.m.-4 p.m., November 16, 2007 (Closed).
    Place: Crowne Plaza Buckhead, 3377 Peachtree Road, NE., Atlanta, 
GA 30326, telephone 404-264-1111.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of ``CDC Grants for Public Health 
Research Dissertation,'' PAR07-231, Panel C.
    Contact Person for More Information: Sheree Marshall Williams, 
Ph.D., M.Sc., Scientific Review Administrator, Office of the Chief 
Science Officer, CDC, 1600 Clifton Road, NE., Mailstop D 72, 
Atlanta, GA 30333, Telephone 404-639-4896.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: September 20, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E7-18947 Filed 9-25-07; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.